Glioblastoma Pipeline Shifts to Biomarker-Guided Combination Therapies
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in ...
A new MD Anderson study finds that pre-existing immune rejection and the intrinsic fitness of donor-derived CAR T cells determine ...
UChicago Medicine has launched a first-of-its-kind investigator-initiated clinical trial of a fully on-site manufactured T-cell receptor therapy engineered to target ...
UCLA researchers used a genome-wide CRISPR screen to identify the Cullin-5 RING E3 ligase complex as a key driver of ...
A systematic review and meta-analysis of 23 studies and 547 patients finds that CD19-directed CAR T-cell therapy delivers encouraging one-year ...
A comprehensive review maps the engineering, biomarker, manufacturing and economic innovations that will determine whether CAR-T cell therapy can move ...
A phase 1 trial found that the investigational BCMA-targeted CAR-T therapy anito-cel produced responses in all 38 participants with relapsed ...
Cold Spring Harbor Laboratory researchers found that activating the transcription factor PPARD in immune cells, including CAR T cells, boosts ...
A phase I trial at Ohio State found that CAR T cells engineered to target three B-cell proteins and boosted ...
Columbia researchers discovered a bacterial antiviral system called DRT10 that shares an evolutionary origin with telomerase, opening new paths for ...
A pharmacovigilance analysis of nearly five million adverse-event reports finds that liver injury after CAR T-cell therapy is predominantly early ...
A new review maps the engineering strategies, from dual-target receptors to tumor microenvironment remodeling, that could finally bring CAR-T cell ...
A new review in the Journal of Translational Medicine charts how CAR-T-cell technology is being adapted from cancer treatment to ...
A Paris case report describes acute spinal cord injury after CAR T cell therapy, likely a rare spinal manifestation of ...
Sylvester Comprehensive Cancer Center researchers report an FDA approval for a pancreatic cancer pill that nearly doubled survival, alongside new ...
A Nature Reviews Cancer review argues that metabolism, from CAR design and manufacturing conditions to the patient's diet, is a ...
Hematologists argue that preventive dental care and oral health assessment should become a standard part of the CAR-T cell therapy ...
The Mount Sinai Tisch Cancer Center has deployed real-time EHR-to-EDC technology across all 16 of its cancer disease groups, cutting ...
An international panel of 31 experts has published updated 2026 consensus recommendations in The Lancet Rheumatology guiding the safe use ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.